CClinicalTrials.gg
RecruitingNCT01255748Updated Sep 29, 2026

Registry Study for Radiation Therapy Outcomes

An observational study in Neoplasms, sponsored by Proton Collaborative Group. Recruiting at 29 sites in United States. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Proton Collaborative Group · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50,000
Sex
All
01

Study summary

The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

02

Conditions studied

  • Neoplasms

Browse trials for

Keywords

  • cancer, proton, radiation
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Radiation Oncology patients

Eligibility criteria

Inclusion Criteria:

  • Planned treatment with radiation therapy
  • Ability to understand and sign IRB approved consent
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50,000 participants (estimated)
Target follow-up
30 Years
Patient registry
Yes

Groups and cohorts

  • Treatment with Radiation Therapy

    Includes 16 different arms to capture patient data by disease site

    Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy

Interventions

  • RadiationProton Therapy, Photon Therapy, SRS, Brachytherapy

    Outcomes Tracking

05

What researchers measure

Primary outcomes

  1. Define outcomes for patients treated at participating institutions

    Time frame: PRN

Secondary outcomes

  1. Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures

    Time frame: Annually PRN

  2. Improve patient care by an adequate understanding of the results and patient population at participating institutions

    Time frame: Reviewed Annually PRN

06

Study locations

29 of 29 sites recruiting
  • Mayo Clinic
    Scottsdale, Arizona 85259-5499, United States
    • Clinical Trials Office - All Mayo Clinic Locations · Contact · 855-776-0015 (toll free)
    Recruiting
  • Proton Center of Arkansas
    Little Rock, Arkansas 72205, United States
    • Monica Coleman · Contact · mmcoleman@uams.edu · 501-686-8274
    • Leslie Harrell, MD · Principal investigator
    Recruiting
  • California Protons Cancer Therapy Center
    San Diego, California 92121, United States
    Recruiting
  • South Florida Proton Therapy Institute
    Delray Beach, Florida 33484, United States
    • Salina Ramirez · Contact · sramirez@sfpti.com · 561-323-6360
    • James Snider, MD · Principal investigator
    Recruiting
  • Southwest Florida Proton Center
    Fort Myers, Florida 33967, United States
    • Krisha Parikh · Contact · kparikh@swflproton.com · 239-516-0009
    • Shannon MacDonald, MD · Principal investigator
    Recruiting
  • Ackerman Cancer Center
    Jacksonville, Florida 32223, United States
    Recruiting
  • Dwoskin Proton Therapy Center
    Miami, Florida 33125, United States
    • Felisa Flores · Contact · fflores2@med.miami.edu · 305-243-4370
    • Matthew Abramowitz, MD · Principal investigator
    Recruiting
  • Miami Cancer Institute
    Miami, Florida 33176, United States
    Recruiting
  • Orlando Health Cancer Institute
    Orlando, Florida 32806, United States
    Recruiting
  • Emory Proton Therapy Center
    Atlanta, Georgia 30308, United States
    • Leann Schilling, MPH, CCRP · Contact · leann.schilling@emory.edu · 404-686-0286
    • Mark McDonald, MD · Principal investigator
    Recruiting
  • OSF HealthCare Cancer Institute
    Peoria, Illinois 61603, United States
    Recruiting
  • Northwestern Medicine Chicago Proton Center
    Warrenville, Illinois 60555, United States
    • Don Smith, MS, CCRC · Contact · donald.smith3@nm.org · 630-933-7820
    • Arpi Thukral, MD · Principal investigator
    Recruiting
  • University of Kansas Proton Therapy Center
    Kansas City, Kansas 66160, United States
    • Amanda Schroeder · Contact · aschroeder3@kumc.edu · 913-588-1617
    • Ronny Rotondo, MD · Principal investigator
    Recruiting
  • Kansas City Proton Institute
    Overland Park, Kansas 66207, United States
    • Judy Searcy · Contact · jsearcy@kcuc.com · 913-647-4173
    • James Coster, MD · Principal investigator
    Recruiting
  • Willis-Knighton Cancer and Proton Therapy Center
    Shreveport, Louisiana 71103, United States
    • Briana Barrow, CCRC · Contact · bbarrow@wkhs.com · 318-212-8671
    • Lane Rosen, MD · Principal investigator
    Recruiting
  • Maryland Proton Treatment Center
    Baltimore, Maryland 21201, United States
    Recruiting
  • McLaren Proton Therapy Center
    Flint, Michigan 48532, United States
    Recruiting
  • Mercy David C. Pratt Cancer Center
    St Louis, Missouri 63141, United States
    Recruiting
  • ProCure Proton Therapy Center
    Somerset, New Jersey 08873, United States
    Recruiting
  • New York Proton Center
    New York, New York 10035, United States
    • Ryan Holder · Contact · rholder@nyproton.com · 646-968-9055
    • Charles Simone, MD, FACRO · Principal investigator
    Recruiting
  • Atrium Health Levine Cancer Proton & Advanced Radiation Center
    Charlotte, North Carolina 28204, United States
    Recruiting
  • University of Cincinnati Medical Center
    Cincinnati, Ohio 45044, United States
    • Christine Vollmer, MBA · Contact · mccordce@ucmail.uc.edu · 513-213-3203
    • Luke Pater, MD · Principal investigator
    Recruiting
  • Oklahoma Proton Center
    Oklahoma City, Oklahoma 73142, United States
    Recruiting
  • Tennessee Oncology Proton Center
    Franklin, Tennessee 37067, United States
    • Erick Vides · Contact · evides@tnonc.com · 615-716-4736
    • James Gray, MD · Principal investigator
    Recruiting
  • Thompson Proton Center
    Knoxville, Tennessee 37909, United States
    • Kristi Simcox · Contact · esimcox@covhlth.com · 865-331-4985
    • Ryan Grover, MD · Principal investigator
    Recruiting
  • Texas Center for Proton Therapy
    Irving, Texas 75063, United States
    Recruiting
  • Inova Schar Cancer Institute
    Fairfax, Virginia 22031, United States
    Recruiting
  • Hampton University Proton Therapy Institute
    Hampton, Virginia 23666, United States
    Recruiting
  • University of Washington
    Seattle, Washington 98195-6043, United States
    • Erica Peters, CCRC, CPM · Contact · etucker@uw.edu · 206-598-7188
    • Annemarie Shepherd, MD · Principal investigator
    Recruiting
07

References and documents

Publications

  • Lee HJ Jr, Macomber MW, Spraker MB, Bowen SR, Hippe DS, Fung A, Russell KJ, Laramore GE, Rengan R, Liao J, Apisarnthanarax S, Zeng J. Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes. Radiat Oncol. 2018 Sep 17;13(1):179. doi: 10.1186/s13014-018-1127-6. PubMed 30223877 ↗
08

Registry details

Key details

Study ID
NCT01255748
Lead sponsor
Proton Collaborative Group
Responsible party
Sponsor
First posted
Dec 7, 2010
Start date
Jun 2009
Primary completion
Jun 2039 (estimated)
Last update
Sep 29, 2026

Study contacts

Carlos Vargas, MD
study chair · Proton Collaborative Group

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion